Key Events This Week
2 Feb: Downgrade to Sell on weak financials and bearish technicals
6 Feb: Positive financial trend reported with revenue growth and margin improvement
6 Feb: Q3 FY26 results highlight margin pressures despite revenue gains
6 Feb: Week closes at Rs.74.33 (-0.72%) vs Sensex +1.51%
Monday, 2 February: Downgrade to Sell Amid Weak Financials and Bearish Technicals
Kriti Nutrients began the week under pressure, closing at Rs.72.70, down 2.90% from the previous close of Rs.74.87. This decline coincided with MarketsMOJO’s downgrade of the stock from Hold to Sell, citing weak financial performance and deteriorating technical indicators. The company’s recent financials revealed a 28.21% decline in PAT for the first nine months of FY25-26, alongside flat quarterly results and a subdued ROCE of 18.32%. Despite a strong Return on Equity of 16.66% and low debt-to-equity ratio of 0.06, concerns over growth and profitability weighed heavily.
Technically, the stock exhibited bearish momentum with negative signals from MACD, Bollinger Bands, and KST indicators, while daily moving averages turned bearish. The stock’s price remained far below its 52-week high of Rs.137.00, reflecting heightened volatility and investor caution. The Sensex also declined 1.03% that day, but Kriti Nutrients underperformed with a sharper drop.
Tuesday, 3 February: Modest Recovery Amid Broad Market Rally
On 3 February, Kriti Nutrients rebounded slightly, closing at Rs.73.31, up 0.84%. This modest gain came alongside a strong Sensex rally of 2.63%, driven by broader market optimism. The stock’s volume surged to 4,137 shares, indicating increased trading interest. However, the recovery was limited, reflecting lingering concerns from the downgrade and weak fundamentals. The stock remained below key resistance levels, and the technical outlook continued to signal caution.
Wednesday, 4 February: Continued Gains on Improving Sentiment
The stock extended its gains on 4 February, closing at Rs.74.40, a 1.49% increase. This was the highest close of the week and coincided with a modest Sensex gain of 0.37%. The improved performance was supported by positive sentiment following early-week weakness and anticipation of upcoming quarterly results. Volume increased further to 5,751 shares, suggesting growing investor interest. Despite this, the stock’s price remained well below its 52-week high, and technical indicators still reflected mixed signals.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
Thursday, 5 February: Slight Pullback Amid Profit Taking
On 5 February, Kriti Nutrients’ stock price dipped marginally by 0.24% to close at Rs.74.22, with volume declining to 1,141 shares. This slight pullback occurred despite the Sensex falling 0.53%, indicating relative stability in the stock amid broader market weakness. The day’s trading suggested some profit-taking after the prior two days’ gains, with investors awaiting the company’s quarterly results and further clarity on financial trends.
Friday, 6 February: Positive Financial Trend Reported Amid Margin Pressures
Kriti Nutrients closed the week at Rs.74.33, up 0.15% on the day, as the company reported a positive financial trend for the quarter ended December 2025. Net sales surged 26.2% to Rs.437.24 crores over the half-year, with PBDIT reaching Rs.11.51 crores and PBT excluding other income at Rs.9.94 crores, marking recent highs. Operational efficiency improved, evidenced by an inventory turnover ratio of 20.91 times and a cash balance of Rs.52.13 crores.
However, margin pressures persisted, with ROCE declining to 18.32%, the lowest in recent periods. The stock’s Mojo Score rose to 58.0, prompting an upgrade from Sell to Hold. Despite these improvements, the share price remained subdued, reflecting cautious market sentiment amid ongoing sector challenges and historical volatility. The Sensex gained 0.10% that day, outperforming Kriti Nutrients marginally.
Holding Kriti Nutrients Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Weekly Price Performance: Kriti Nutrients vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-02 | Rs.72.70 | -2.90% | 35,814.09 | -1.03% |
| 2026-02-03 | Rs.73.31 | +0.84% | 36,755.96 | +2.63% |
| 2026-02-04 | Rs.74.40 | +1.49% | 36,890.21 | +0.37% |
| 2026-02-05 | Rs.74.22 | -0.24% | 36,695.11 | -0.53% |
| 2026-02-06 | Rs.74.33 | +0.15% | 36,730.20 | +0.10% |
Key Takeaways
Positive Signals: Kriti Nutrients demonstrated a strong revenue growth of 26.2% in the latest half-year, with improved operational efficiency and liquidity. The upgrade in Mojo Grade from Sell to Hold reflects a cautious optimism based on recent financial improvements. The stock’s inventory turnover ratio of 20.91 times and cash reserves of Rs.52.13 crores provide a solid operational foundation.
Cautionary Signals: Despite revenue gains, margin pressures persist with ROCE declining to 18.32%, indicating less efficient capital utilisation. The stock underperformed the Sensex over the week and the past year, with a 41.99% decline compared to the Sensex’s 6.32% gain. Technical indicators remain mixed to bearish, and the share price remains well below its 52-week high of Rs.137.00, reflecting ongoing volatility and investor caution.
Market Context: The edible oil sector’s competitive pressures and raw material price volatility continue to challenge Kriti Nutrients’ profitability. While recent operational improvements are encouraging, sustained margin expansion and capital efficiency will be critical for longer-term value creation.
Conclusion
Kriti Nutrients Ltd’s week was characterised by a sharp downgrade early on, followed by a positive financial trend report that led to a Mojo Grade upgrade. The stock’s price performance was subdued, closing the week down 0.72% against a 1.51% gain in the Sensex. The company’s robust revenue growth and improved operational metrics offer a cautiously optimistic outlook, yet persistent margin pressures and mixed technical signals temper enthusiasm. Investors should monitor upcoming quarterly results and sector developments closely to gauge whether the recent momentum can be sustained amid ongoing challenges.
Unlock special upgrade rates for a limited period. Start Saving Now →
